123 related articles for article (PubMed ID: 37353431)
1. Impact of Beta Blockers on Breast Cancer Incidence and Prognosis.
Yang J; Zhang S; Jiang W
Clin Breast Cancer; 2023 Aug; 23(6):664-671.e21. PubMed ID: 37353431
[TBL] [Abstract][Full Text] [Related]
2. Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study.
Hsieh HH; Wu TY; Chen CH; Kuo YH; Hour MJ
Ther Adv Drug Saf; 2023; 14():20420986231181338. PubMed ID: 37359444
[TBL] [Abstract][Full Text] [Related]
3. β-Blocker use is not associated with improved clinical outcomes in women with breast cancer: a meta-analysis.
Li C; Li T; Tang R; Yuan S; Zhang W
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32436935
[TBL] [Abstract][Full Text] [Related]
4. Beta blockers and improved progression-free survival in patients with advanced HER2 negative breast cancer: a retrospective analysis of the ROSE/TRIO-012 study.
Spera G; Fresco R; Fung H; Dyck JRB; Pituskin E; Paterson I; Mackey JR
Ann Oncol; 2017 Aug; 28(8):1836-1841. PubMed ID: 28520849
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and toxicity of extended aromatase inhibitors after adjuvant aromatase inhibitors-containing therapy for hormone-receptor-positive breast cancer: a literature-based meta-analysis of randomized trials.
Qian X; Li Z; Ruan G; Tu C; Ding W
Breast Cancer Res Treat; 2020 Jan; 179(2):275-285. PubMed ID: 31606823
[TBL] [Abstract][Full Text] [Related]
6. Platinum-containing regimens for metastatic breast cancer.
Egger SJ; Willson ML; Morgan J; Walker HS; Carrick S; Ghersi D; Wilcken N
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003374. PubMed ID: 28643430
[TBL] [Abstract][Full Text] [Related]
7. The reciprocal influences of prognosis between two types of surgical interventions and early breast cancer patients with diverse luminal subtypes: A meta-analysis.
He L; Zhao S; Liu M; Su Z; Ren Y; Song Y
Medicine (Baltimore); 2019 Mar; 98(11):e14912. PubMed ID: 30882711
[TBL] [Abstract][Full Text] [Related]
8. Risk-reducing medications for primary breast cancer: a network meta-analysis.
Mocellin S; Goodwin A; Pasquali S
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012191. PubMed ID: 31032883
[TBL] [Abstract][Full Text] [Related]
9. Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis.
Ji Y; Wang H
World J Surg Oncol; 2020 Aug; 18(1):197. PubMed ID: 32767977
[TBL] [Abstract][Full Text] [Related]
10. Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study.
Nottage MK; Kopciuk KA; Tzontcheva A; Andrulis IL; Bull SB; Blackstein ME
Breast Cancer Res; 2006; 8(4):R44. PubMed ID: 16859523
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of platinum-based and non-platinum-based drugs on triple-negative breast cancer: meta-analysis.
Lin C; Cui J; Peng Z; Qian K; Wu R; Cheng Y; Yin W
Eur J Med Res; 2022 Oct; 27(1):201. PubMed ID: 36242046
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of occult lymph node metastases in breast cancer: a meta-analysis.
Wang G; Zhang S; Wang M; Liu L; Liu Y; Tang L; Bai H; Zhao H
BMC Cancer; 2021 Jul; 21(1):875. PubMed ID: 34330233
[TBL] [Abstract][Full Text] [Related]
13. The prognosis of breast cancer patients after mastectomy and immediate breast reconstruction: a meta-analysis.
Yang X; Zhu C; Gu Y
PLoS One; 2015; 10(5):e0125655. PubMed ID: 26024490
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
Wu SY; Tan Y; Guan YS
Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
[TBL] [Abstract][Full Text] [Related]
15. Extended Adjuvant Therapy With Aromatase Inhibitors for Early Breast Cancer: A Meta-analysis of Randomized Controlled Trials.
Xu L; Zhang Z; Xiang Q; Liu Q; Duan X; Liu Y; Cui Y
Clin Breast Cancer; 2019 Oct; 19(5):e578-e588. PubMed ID: 31257015
[TBL] [Abstract][Full Text] [Related]
16. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
Gao ZH; Li CX; Liu M; Jiang JY
BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
[TBL] [Abstract][Full Text] [Related]
17. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies.
Dong JY; Qin LQ
Breast Cancer Res Treat; 2011 Jan; 125(2):315-23. PubMed ID: 21113655
[TBL] [Abstract][Full Text] [Related]
18. Association of Cyclin-Dependent Kinases 4 and 6 Inhibitors With Survival in Patients With Hormone Receptor-Positive Metastatic Breast Cancer: A Systematic Review and Meta-analysis.
Li J; Huo X; Zhao F; Ren D; Ahmad R; Yuan X; Du F; Zhao J
JAMA Netw Open; 2020 Oct; 3(10):e2020312. PubMed ID: 33048129
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of randomized controlled trials comparing the efficacy and safety of anastrozole versus tamoxifen for breast cancer.
Yang Y; Pan W; Tang X; Wu S; Sun X
Oncotarget; 2017 Jul; 8(29):48362-48374. PubMed ID: 28415634
[TBL] [Abstract][Full Text] [Related]
20. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
Bui KT; Willson ML; Goel S; Beith J; Goodwin A
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
